Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Women More Likely to Be Affected by Moyamoya Disease

By HospiMedica International staff writers
Posted on 24 May 2010
Women are more likely than men to be affected by Moyamoya disease (MMD), have a higher risk of initially presenting with a transient ischemic attack (TIA), and are about twice as likely to have an adverse postoperative event, according to a new study.

Researchers at Stanford University (CA, USA) examined a large series of 433 consecutive MMD patients (mean age of 31 years) to determine whether sex differences exist in presentation and treatment outcomes after cerebral revascularization. More...
Preoperative evaluation of the patients included clinical presentation, cerebral magnetic resonance imaging (MRI), 6-vessel angiography, and perfusion studies. All 433 patients underwent 724 revascularization procedures between 1991 and January 2010 by a single physician. The postoperative evaluation included similar studies at a minimum of 6 months, and then at 3 and 10 years. New events and neurologic deficits associated with a new infarct or hemorrhage lasting 24 hours or longer after revascularization surgery were recorded; abilities to perform activities of daily living were gauged using the modified Rankin Scale (mRS).

The study results for 403 evaluable patients involved 717 revascularization procedures. The researchers found that the female to male ratio was 2.5:1 (307 females to 123 males). No differences between sexes were found for race or ethnicity (58.6% white and 30.9% Asian), hypertension, smoking history, or hyperlipidemia. Men and women were equally likely to present with ischemic or hemorrhagic strokes, headaches, or seizures. Postoperatively, both men and women showed significant improvement on the mRS. Postoperative adverse events in occurred in 40 patients (9.9%) and included hemorrhage and ischemic stroke. A Kaplan-Meier analysis of event-free survival suggested that women were at twice the cumulative risk for an adverse event at 5 years from their first surgery: 11.9% for women compared to 5.3% for men. The study was presented at the American Association of Neurological Surgeons annual meeting, held during May 2010 in Philadelphia (PA, USA).

"The females in our cohort were more likely to present with TIAs than the males. That may be important because that may give us a clue as to how the disease is acting preferentially in women versus men,” said senior author and study presenter Gary Steinberg, M.D., Ph.D., chairman of neurosurgery and professor of neurosurgery and the neurosciences at Stanford. "About half of those patients recover completely. No hemorrhage has ever been seen at the site of anastomosis of the vessels.”

MMD is a rare, progressive cerebral angiopathy in which the main arteries of the brain, the internal carotid, anterior, and middle cerebral arteries, as well as the circle of Willis, are narrowed or occluded bilaterally, probably from migration and proliferation of vascular smooth muscle cells within the arteries, causing TIAs. Loss of function manifests as limb weakness, sensory disturbances, epileptic seizures, or headaches. Thin, weak collateral vessels form in the brain in reaction to the occlusions. These vessels, prone to hemorrhage, aneurysm, and thrombosis, form a cloudlike appearance on radiographic imaging, giving the disease its name, "moyamoya,” which in Japanese means "puff of smoke.”

Related Links
Stanford University



Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Ureteral Dilatation Balloon
Dornier Equinox
Surgical Headlight
IsoTorch
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The 3D-printed microneedle patch boosts live-virus vaccine delivery (Photo courtesy of IIS/University of Tokyo)

3D-Printed Delivery System Enhances Vaccine Delivery Via Microneedle Array Patch

The COVID-19 pandemic underscored the need for efficient, durable, and widely accessible vaccines. Conventional vaccination requires trained personnel and cold-chain logistics, which can slow mass immunization... Read more

Surgical Techniques

view channel
Image: The AI-based approach identifies lipid regions matched well with histopathology results (Photo courtesy of Hyeong Soo Nam/KAIST)

AI-Based OCT Image Analysis Identifies High-Risk Plaques in Coronary Arteries

Lipid-rich plaques inside coronary arteries are strongly associated with heart attacks and other major cardiac events. While optical coherence tomography (OCT) provides detailed images of vessel structure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.